Tech startups such as Wonderful, Onodrim Industries, Adonis, among others have announced their venture capital funding to bolster innovation and business growth.
Wonderful Raises $150 mn Series B to Accelerate Enterprise AI Adoption
Wonderful raised $150 million in a Series B led by Insight Partners with participation from Index Ventures, IVP, Bessemer Venture Partners, and Vine Ventures. The funds will accelerate global expansion, grow headcount substantially, and deepen deployment of its enterprise AI agent platform across telecom, finance, manufacturing, and healthcare. Wonderful’s strategy emphasizes localized deployment teams embedding AI agents into enterprise workflows. The capital reflects strong demand for production grade agentic AI adoption and infrastructure that couples global technology with local operational support.
Onodrim Industries Raises €40M Seed to Advance Defence Tech
Onodrim Industries raised €40 million in seed funding led by Founders Fund, Lakestar, and General Catalyst, with participation from other global investors. The capital will accelerate development of its European defence and industrial technology platform focusing on multi domain sensing, defence manufacturing, and networked systems. Onodrim aims to build strategic infrastructure technologies that strengthen deterrence and resilience across European and allied forces, addressing challenges such as border protection and secure supply chains. This funding signals broad investor interest in dual use, mission critical technology innovation and infrastructure resilience.
Adonis Raises $40 mn Series C for AI Driven Healthcare Operations
Adonis announced a $40 million Series C round led by Quadrille Capital with continued support from General Catalyst and Bling Capital. The funding brings total investment to $95 million and will expand its AI orchestration platform for healthcare revenue cycle management (RCM). Adonis uses AI to proactively detect and automate resolution of revenue issues, improving financial performance and operational efficiency for providers amid evolving payer landscapes. The capital will support product enhancement, go to market scaling, and deployment across health systems facing complex reimbursement challenges.
THASNIYA VP
